SRRK Stock Summary and Trading Ideas (Scholar Rock Holding | NASDAQ:SRRK)

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Scholar Rock Holding trades on the NASDAQ stock market under the symbol SRRK.

As of February 27, 2026, SRRK stock price declined to $44.27 with 1,150,790 million shares trading.

SRRK has a beta of 0.84, meaning it tends to be less sensitive to market movements. SRRK has a correlation of 0.05 to the broad based SPY ETF.

SRRK has a market cap of $4.52 billion. This is considered a Mid Cap stock.

Last quarter Scholar Rock Holding reported $0 in Revenue and -$.90 earnings per share. This fell short of revenue expectation by $-50,000 and missed earnings estimates by -$.05.

In the last 3 years, SRRK traded as high as $49.82 and as low as $5.56.

The top ETF exchange traded funds that SRRK belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWO.

SRRK has outperformed the market in the last year with a return of +23.1%, while the SPY ETF gained +18.5%. In the last 3 month period, SRRK beat the market returning +2.6%, while SPY returned +1.2%. However, in the most recent 2 weeks SRRK has underperformed the stock market by returning -3.7%, while SPY returned +0.6%.

SRRK support price is $43.52 and resistance is $46.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SRRK shares will trade within this expected range on the day.